3 Stocks Advancing The Health Services Industry

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 45.88 points (-0.3%) at 17,054 as of Monday, July 21, 2014, 3:55 PM ET. The NYSE advances/declines ratio sits at 1,120 issues advancing vs. 1,886 declining with 123 unchanged.

The Health Services industry as a whole closed the day down 0.2% versus the S&P 500, which was down 0.2%. Top gainers within the Health Services industry included Pro-Dex ( PDEX), up 5.6%, Lakeland Industries ( LAKE), up 1.9%, Akers Biosciences ( AKER), up 2.0%, ERBA Diagnostics ( ERB), up 7.8% and Amedica Corporation ( AMDA), up 1.9%.

TheStreet Ratings Group would like to highlight 3 stocks pushing the industry higher today:

Amedica Corporation ( AMDA) is one of the companies that pushed the Health Services industry higher today. Amedica Corporation was up $0.08 (1.9%) to $4.28 on heavy volume. Throughout the day, 64,582 shares of Amedica Corporation exchanged hands as compared to its average daily volume of 24,400 shares. The stock ranged in a price between $4.16-$4.36 after having opened the day at $4.16 as compared to the previous trading day's close of $4.20.

Amedica Corporation has a market cap of $49.7 million and is part of the health care sector. Shares are unchanged year-to-date as of the close of trading on Friday.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Highlights from TheStreet Ratings analysis on AMDA go as follows:

You can view the full analysis from the report here: Amedica Corporation Ratings Report

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

At the close, Akers Biosciences ( AKER) was up $0.08 (2.0%) to $3.95 on light volume. Throughout the day, 4,700 shares of Akers Biosciences exchanged hands as compared to its average daily volume of 15,500 shares. The stock ranged in a price between $3.88-$3.97 after having opened the day at $3.88 as compared to the previous trading day's close of $3.87.

Akers Biosciences has a market cap of $19.1 million and is part of the health care sector. Shares are down 47.0% year-to-date as of the close of trading on Friday.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Highlights from TheStreet Ratings analysis on AKER go as follows:

You can view the full analysis from the report here: Akers Biosciences Ratings Report

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Lakeland Industries ( LAKE) was another company that pushed the Health Services industry higher today. Lakeland Industries was up $0.12 (1.9%) to $6.54 on light volume. Throughout the day, 2,988 shares of Lakeland Industries exchanged hands as compared to its average daily volume of 8,500 shares. The stock ranged in a price between $6.42-$6.65 after having opened the day at $6.42 as compared to the previous trading day's close of $6.42.

Lakeland Industries, Inc., together with its subsidiaries, manufactures and sells safety garments and accessories for the industrial protective clothing market worldwide. Lakeland Industries has a market cap of $35.0 million and is part of the health care sector. Shares are up 22.2% year-to-date as of the close of trading on Friday. Currently there are no analysts who rate Lakeland Industries a buy, no analysts rate it a sell, and none rate it a hold.

TheStreet Ratings rates Lakeland Industries as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including generally higher debt management risk and poor profit margins.

Highlights from TheStreet Ratings analysis on LAKE go as follows:

  • The net income growth from the same quarter one year ago has significantly exceeded that of the S&P 500 and the Textiles, Apparel & Luxury Goods industry. The net income increased by 100.0% when compared to the same quarter one year prior, rising from -$0.84 million to $0.00 million.
  • Despite its growing revenue, the company underperformed as compared with the industry average of 8.5%. Since the same quarter one year prior, revenues slightly increased by 8.1%. Growth in the company's revenue appears to have helped boost the earnings per share.
  • LAKELAND INDUSTRIES INC reported significant earnings per share improvement in the most recent quarter compared to the same quarter a year ago. The company has demonstrated a pattern of positive earnings per share growth over the past year. During the past fiscal year, LAKELAND INDUSTRIES INC turned its bottom line around by earning $0.00 versus -$4.88 in the prior year.
  • The gross profit margin for LAKELAND INDUSTRIES INC is currently lower than what is desirable, coming in at 31.80%. Regardless of LAKE's low profit margin, it has managed to increase from the same period last year. Despite the mixed results of the gross profit margin, the net profit margin of 0.00% trails the industry average.
  • Despite currently having a low debt-to-equity ratio of 0.41, it is higher than that of the industry average, inferring that management of debt levels may need to be evaluated further. Despite the fact that LAKE's debt-to-equity ratio is mixed in its results, the company's quick ratio of 0.70 is low and demonstrates weak liquidity.

You can view the full analysis from the report here: Lakeland Industries Ratings Report

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

More from Markets

U.S. Banks Pass Fed 'Stress Test' With Room for Dividends, Buybacks

U.S. Banks Pass Fed 'Stress Test' With Room for Dividends, Buybacks

Comcast's Brian Roberts vs. Disney's Bob Iger: Which Titan Will Nab Fox?

Comcast's Brian Roberts vs. Disney's Bob Iger: Which Titan Will Nab Fox?

Online Retailers Hit by Supreme Court Ruling Requiring Sales Tax Collection

Online Retailers Hit by Supreme Court Ruling Requiring Sales Tax Collection

Dow Logs Eighth Straight Drop as Stocks Slump

Dow Logs Eighth Straight Drop as Stocks Slump

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech